- CERS has an average dollar-volume (as measured by average daily share volume multiplied by share price) of $15.2 million.
- CERS traded 261,818 shares today in the pre-market hours as of 9:08 AM, representing 11.9% of its average daily volume.
EXCLUSIVE OFFER: Get the inside scoop on opportunities in CERS with the Ticky from Trade-Ideas. See the FREE profile for CERS NOW at Trade-Ideas More details on CERS: Cerus Corporation, together with its subsidiary, Cerus Europe B.V., operates as a biomedical products company in Europe, the Commonwealth of Independent States, and the Middle East. The company develops and commercializes the INTERCEPT Blood System to enhance blood safety. Currently there are 3 analysts that rate Cerus a buy, no analysts rate it a sell, and none rate it a hold. The average volume for Cerus has been 1.1 million shares per day over the past 30 days. Cerus has a market cap of $374.1 million and is part of the health care sector and drugs industry. The stock has a beta of 2.68 and a short float of 19.2% with 5.50 days to cover. Shares are down 9.2% year-to-date as of the close of trading on Wednesday.